|
🐜
|
Molecular MRD status and outcome after transplantation in NPM1 mutated AML: results from the UK NCRI AML17 study.
44 auth.
R. Dillon,
R. Dillon,
R. Hills,
S. Freeman,
N. Potter,
N. Potter,
J. Jovanovic,
Adam Ivey,
Anju Kanda,
Manohursingh Runglall,
N. Foot,
M. Valgañón,
A. Khwaja,
J. Cavenagh,
Matthew L. Smith,
...
H. Ommen,
U. Overgaard,
M. Dennis,
S. Knapper,
H. Kaur,
D. Taussig,
P. Mehta,
K. Raj,
Igor Novitzky-Basso,
E. Nikolousis,
R. Danby,
P. Krishnamurthy,
K. Hill,
D. Finnegan,
S. Alimam,
S. Alimam,
E. Hurst,
P. Johnson,
A. Khan,
R. Salim,
C. Craddock,
R. Spearing,
A. Gilkes,
R. Gale,
A. Burnett,
N. Russell,
N. Russell,
D. Grimwade,
D. Grimwade
|
6 |
2019 |
6
🐜
|
|
🐜
|
Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia
22 auth.
C. Craddock,
S. Nagra,
A. Peniket,
C. Brookes,
L. Buckley,
E. Nikolousis,
N. Duncan,
S. Tauro,
J. Yin,
E. Liakopoulou,
...
P. Kottaridis,
J. Snowden,
D. Milligan,
G. Cook,
E. Tholouli,
T. Littlewood,
K. Peggs,
P. Vyas,
F. Clark,
M. Cook,
S. Mackinnon,
N. Russell
|
6 |
2010 |
6
🐜
|
|
🐜
|
Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study.
108 auth.
E. Petersdorf,
E. Petersdorf,
M. Carrington,
C. O’hUigin,
M. Bengtsson,
D. D. Santis,
V. Dubois,
T. Gooley,
M. Horowitz,
M. Horowitz,
K. Hsu,
J. A. Madrigal,
M. Maiers,
M. Malkki,
Caroline McKallor,
...
Y. Morishima,
M. Oudshoorn,
S. Spellman,
J. Villard,
Philip Stevenson,
M. Maiers,
S. Spellman,
J. Apperley,
Peter Bardy,
Ghislaine Bernard,
Yves Bertrand,
A. Bloor,
C. Bonini,
Stéphane Buhler,
L. Bungener,
Helen Campbell,
K. Carlson,
B. Carpenter,
A. Cesbron,
C. Chabannon,
Y. Chalandon,
Jeremy Chapman,
Réda Chebel,
P. Chevallier,
Gerda Choi,
Matthew Collin,
J. Cornelissen,
C. Crawley,
Lloyd D'Orsogna,
J. Dalle,
E. Deconinck,
Muriel DeMatteis,
M. Diviney,
A. Dormoy,
Katia Gagne,
B. Gibson,
Maria Gilleece,
David Gottlieb,
John G. Gribben,
T. Güngör,
M. Haagenson,
Cathie F Hart,
Rhonda Holdsworth,
Ian Humphreys,
Y. Kodera,
Mickey Koh,
H. Labussière-Wallet,
A. Lankester,
Neubery Lardy,
Sarah Lawson,
X. Leleu,
S. Mackinnon,
R. Malladi,
S. Marsh,
Murray Martin,
N. Mayor,
I. McQuaker,
E. Meijer,
S. Morishima,
E. Nikolousis,
Kim H. Orchard,
J. Passweg,
Amit Patel,
Katherine Patrick,
B. Pedron,
Andy Peniket,
J. Perry,
E. Petersen,
V. Potter,
Michael Potter,
R. Protheroe,
N. Raus,
C. Elvira,
N. H. Russell,
Nicholaas Pm Schaap,
U. Schanz,
H. Schouten,
Roderick Skinner,
John A. Snowden,
Eric Spierings,
Colin G. Steward,
E. Tholouli,
A. Thornton,
Marcel G. J. Tilanus,
Arnold van de Meer,
Hendrik Veelkens,
P. Veys,
Narelle Watson,
L. Weston,
Keith M O Wilson,
M. Wilson,
R. Wynn,
J. Zsiros
|
5 |
2019 |
5
🐜
|
|
🦁
|
Allogeneic transplant outcomes are not affected by body mass index (BMI) in patients with haematological malignancies
9 auth.
E. Nikolousis,
S. Nagra,
S. Paneesha,
J. Delgado,
K. Holder,
Lynn Bratby,
...
S. Chaganti,
R. Lovell,
D. Milligan
|
5 |
2010 |
5
🦁
|
|
🐢
|
COVID‐19 in bone marrow transplant recipients: reflecting on a single centre experience
18 auth.
A. Kanellopoulos,
Maria Z Ahmed,
B. Kishore,
R. Lovell,
Claire Horgan,
Paneesha Shankara,
R. Lloyd,
B. Salhan,
H. Giles,
S. Chauhan,
...
I. Venkatadasari,
Muhammad Khakwani,
Vidhya Murthy,
Evgenia Xenou,
H. Dassanayake,
Swathy Srinath,
M. Kaparou,
E. Nikolousis
|
5 |
2020 |
5
🐢
|
|
🐜
|
Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective study
25 auth.
J. Styczyński,
G. Tridello,
A. Xhaard,
M. Medinger,
S. Mielke,
M. Taskinen,
N. Blijlevens,
M. B. Rodriguez,
C. Solano,
E. Nikolousis,
A. Biffi,
A. Groll,
C. Junghanss,
P. Tsirigotis,
B. Lioure,
...
J. Šrámek,
E. Holler,
F. Galaverna,
F. Fagioli,
N. Knelange,
L. Wendel,
L. Gil,
R. de la Cámara,
M. Mikulska,
P. Ljungman
|
4 |
2020 |
4
🐜
|
|
🐬
|
Intestinal lymphoma—a review of the management of emergency presentations to the general surgeon
S. Abbott,
E. Nikolousis,
I. Badger
|
4 |
2015 |
4
🐬
|
|
🐜
|
Reduced CD38 expression on CD34+ cells as a diagnostic test in myelodysplastic syndromes
11 auth.
N. Goardon,
E. Nikolousis,
A. Sternberg,
Wai-Kit Chu,
C. Craddock,
P. Richardson,
...
Richard Benson,
M. Drayson,
G. Standen,
P. Vyas,
S. Freeman
|
4 |
2009 |
4
🐜
|
